1
NATERA INC
COM
NTRA
NTRA
1,778,051
$162.6m12.15%
12.15%
Reduced Shares held: Q2 2023 2.4m, Q3 2023 2.5m, Q4 2023 2.3m, Q1 2024 1.8m
-473.5k
-473,537
-21.0%
2
GSK PLC
SPONSORED ADR
GSK
GSK
3,771,994
$161.7m12.08%
12.08%
Added Shares held: Q2 2023 2.9m, Q3 2023 3.3m, Q4 2023 3.0m, Q1 2024 3.8m
+799.0k
+799,040
26.9%
3
INSPIRE MED SYS INC
COM
INSP
INSP
420,699
$90.4m6.75%
6.75%
Added Shares held: Q2 2023 82.4k, Q3 2023 193.0k, Q4 2023 351.1k, Q1 2024 420.7k
+69.6k
+69,583
19.8%
4
TEVA PHARMACEUTICAL INDS LTD
SPONSORED ADS
SPONSORED ADS
6,025,169
$85.0m6.35%
6.35%
Reduced Shares held: Q2 2023 7.7m, Q3 2023 7.0m, Q4 2023 6.2m, Q1 2024 6.0m
-129.2k
-129,185
-2.1%
5
VERA THERAPEUTICS INC
CL A
VERA
VERA
1,823,781
$78.6m5.88%
5.88%
Reduced Shares held: Q2 2023 1.7m, Q3 2023 1.5m, Q4 2023 1.9m, Q1 2024 1.8m
-91.0k
-91,049
-4.8%
6
SYNDAX PHARMACEUTICALS INC
COM
SNDX
SNDX
3,133,113
$74.6m5.57%
5.57%
Reduced Shares held: Q2 2023 2.2m, Q3 2023 2.6m, Q4 2023 3.4m, Q1 2024 3.1m
-250.1k
-250,131
-7.4%
7
UNITED THERAPEUTICS CORP DEL
COM
UTHR
UTHR
251,135
$57.7m4.31%
4.31%
Added Shares held: Q2 2023 260.4k, Q3 2023 267.9k, Q4 2023 246.2k, Q1 2024 251.1k
+4.9k
+4,901
2.0%
8
REVVITY INC
COM
RVTY
RVTY
483,160
$50.7m3.79%
3.79%
Added Shares held: Q2 2023 21.3k, Q3 2023 32.7k, Q4 2023 183.1k, Q1 2024 483.2k
+300.1k
+300,101
163.9%
9
BIO-TECHNE CORP
COM
TECH
TECH
607,687
$42.8m3.20%
3.20%
Added Shares held: Q2 2023 342.6k, Q3 2023 385.9k, Q4 2023 465.3k, Q1 2024 607.7k
+142.4k
+142,380
30.6%
10
HCA HEALTHCARE INC
COM
HCA
HCA
103,821
$34.6m2.59%
2.59%
Reduced Shares held: Q2 2023 80.7k, Q3 2023 110.1k, Q4 2023 114.8k, Q1 2024 103.8k
-11.0k
-10,984
-9.6%
11
HEALTHEQUITY INC
COM
HQY
HQY
421,345
$34.4m2.57%
2.57%
Reduced Shares held: Q2 2023 0, Q3 2023 338.5k, Q4 2023 494.9k, Q1 2024 421.3k
-73.6k
-73,574
-14.9%
12
PFIZER INC
COM
PFE
PFE
1,102,042
$30.6m2.29%
2.29%
New Shares held: Q2 2023 0, Q3 2023 0, Q4 2023 0, Q1 2024 1.1m
13
CELLDEX THERAPEUTICS INC NEW
COM NEW
CLDX
CLDX
711,115
$29.8m2.23%
2.23%
Reduced Shares held: Q2 2023 785.7k, Q3 2023 588.1k, Q4 2023 754.1k, Q1 2024 711.1k
-43.0k
-42,992
-5.7%
14
COMMUNITY HEALTH SYS INC NEW
COM
CYH
CYH
7,980,641
$27.9m2.09%
2.09%
Added Shares held: Q2 2023 7.3m, Q3 2023 7.1m, Q4 2023 7.2m, Q1 2024 8.0m
+749.5k
+749,515
10.4%
15
SHOCKWAVE MED INC
COM
SWAV
SWAV
80,555
$26.2m1.96%
1.96%
Added Shares held: Q2 2023 20.1k, Q3 2023 84.5k, Q4 2023 75.8k, Q1 2024 80.6k
+4.7k
+4,733
6.2%
16
ARGENX SE
SPONSORED ADR
ARGX
ARGX
54,518
$21.5m1.60%
1.60%
Reduced Shares held: Q2 2023 4.2k, Q3 2023 4.6k, Q4 2023 85.8k, Q1 2024 54.5k
-31.3k
-31,314
-36.5%
17
TENET HEALTHCARE CORP
COM NEW
THC
THC
175,631
$18.5m1.38%
1.38%
Reduced Shares held: Q2 2023 0, Q3 2023 0, Q4 2023 187.3k, Q1 2024 175.6k
-11.6k
-11,634
-6.2%
18
IONIS PHARMACEUTICALS INC
COM
IONS
IONS
376,438
$16.3m1.22%
1.22%
Added Shares held: Q2 2023 241.6k, Q3 2023 252.4k, Q4 2023 324.7k, Q1 2024 376.4k
+51.8k
+51,784
15.9%
19
VIATRIS INC
COM
VTRS
VTRS
1,316,469
$15.7m1.17%
1.17%
New Shares held: Q2 2023 0, Q3 2023 0, Q4 2023 0, Q1 2024 1.3m
20
VAXCYTE INC
COM
PCVX
PCVX
197,331
$13.5m1.01%
1.01%
Reduced Shares held: Q2 2023 195.7k, Q3 2023 190.4k, Q4 2023 233.8k, Q1 2024 197.3k
-36.5k
-36,508
-15.6%
21
HUMANA INC
COM
HUM
HUM
35,532
$12.3m0.92%
0.92%
Added Shares held: Q2 2023 11.9k, Q3 2023 18.1k, Q4 2023 1.9k, Q1 2024 35.5k
+33.6k
+33,618
1756.4%
22
PROTAGONIST THERAPEUTICS INC
COM
PTGX
PTGX
411,478
$11.9m0.89%
0.89%
Reduced Shares held: Q2 2023 114.7k, Q3 2023 286.7k, Q4 2023 538.1k, Q1 2024 411.5k
-126.6k
-126,596
-23.5%
23
TARO PHARMACEUTICAL INDS LTD
SHS
TARO
TARO
263,541
$11.2m0.83%
0.83%
Added Shares held: Q2 2023 250.3k, Q3 2023 255.3k, Q4 2023 256.0k, Q1 2024 263.5k
+7.6k
+7,553
3.0%
24
MANNKIND CORP
COM NEW
MNKD
MNKD
2,391,128
$10.8m0.81%
0.81%
New Shares held: Q2 2023 0, Q3 2023 0, Q4 2023 0, Q1 2024 2.4m
25
DANAHER CORPORATION
COM
DHR
DHR
40,855
$10.2m0.76%
0.76%
Reduced Shares held: Q2 2023 103.3k, Q3 2023 103.8k, Q4 2023 41.0k, Q1 2024 40.9k
-186
-186
-0.5%
26
ELI LILLY & CO
COM
LLY
LLY
12,877
$10.0m0.75%
0.75%
New Shares held: Q2 2023 0, Q3 2023 0, Q4 2023 0, Q1 2024 12.9k
27
ZIMVIE INC
COM
ZIMV
ZIMV
564,498
$9.3m0.70%
0.70%
Added Shares held: Q2 2023 0, Q3 2023 0, Q4 2023 546.4k, Q1 2024 564.5k
+18.1k
+18,054
3.3%
28
GUARDANT HEALTH INC
COM
GH
GH
449,586
$9.3m0.69%
0.69%
New Shares held: Q2 2023 0, Q3 2023 0, Q4 2023 0, Q1 2024 449.6k
29
BROOKDALE SR LIVING INC
COM
BKD
BKD
1,318,765
$8.7m0.65%
0.65%
New Shares held: Q2 2023 0, Q3 2023 0, Q4 2023 0, Q1 2024 1.3m
30
NEWAMSTERDAM PHARMA COMPANY
ORDINARY SHARES
NAMS
NAMS
353,965
$8.4m0.63%
0.63%
Reduced Shares held: Q2 2023 692.4k, Q3 2023 660.6k, Q4 2023 374.4k, Q1 2024 354.0k
-20.4k
-20,439
-5.5%
31
IMMUNOVANT INC
COM
IMVT
IMVT
255,526
$8.3m0.62%
0.62%
Added Shares held: Q2 2023 0, Q3 2023 0, Q4 2023 113.8k, Q1 2024 255.5k
+141.7k
+141,733
124.5%
32
NOVO-NORDISK A S
ADR
NVO
NVO
62,344
$8.0m0.60%
0.60%
New Shares held: Q2 2023 0, Q3 2023 0, Q4 2023 0, Q1 2024 62.3k
33
KARYOPHARM THERAPEUTICS INC
COM
COM
5,016,320
$7.6m0.57%
0.57%
New Shares held: Q2 2023 0, Q3 2023 0, Q4 2023 0, Q1 2024 5.0m
34
PUMA BIOTECHNOLOGY INC
COM
PBYI
PBYI
1,426,497
$7.6m0.57%
0.57%
Reduced Shares held: Q2 2023 1.7m, Q3 2023 1.7m, Q4 2023 1.7m, Q1 2024 1.4m
-268.5k
-268,524
-15.8%
35
ELEVANCE HEALTH INC
COM
ELV
ELV
14,393
$7.5m0.56%
0.56%
Reduced Shares held: Q2 2023 2.3k, Q3 2023 21.7k, Q4 2023 15.1k, Q1 2024 14.4k
-701
-701
-4.6%
36
TRAVERE THERAPEUTICS INC
COM
TVTX
TVTX
955,618
$7.4m0.55%
0.55%
New Shares held: Q2 2023 0, Q3 2023 0, Q4 2023 0, Q1 2024 955.6k
37
CENTENE CORP DEL
COM
CNC
CNC
92,786
$7.3m0.54%
0.54%
Reduced Shares held: Q2 2023 152.7k, Q3 2023 190.6k, Q4 2023 97.2k, Q1 2024 92.8k
-4.4k
-4,412
-4.5%
38
BIOCRYST PHARMACEUTICALS INC
COM
BCRX
BCRX
1,432,427
$7.3m0.54%
0.54%
Reduced Shares held: Q2 2023 2.4m, Q3 2023 2.5m, Q4 2023 1.5m, Q1 2024 1.4m
-96.6k
-96,620
-6.3%
39
GOSSAMER BIO INC
COM
GOSS
GOSS
5,994,472
$7.1m0.53%
0.53%
Reduced Shares held: Q2 2023 749.7k, Q3 2023 4.4m, Q4 2023 6.4m, Q1 2024 6.0m
-438.2k
-438,243
-6.8%
40
TAYSHA GENE THERAPIES INC
COM SHS
TSHA
TSHA
2,325,591
$6.7m0.50%
0.50%
Reduced Shares held: Q2 2023 0, Q3 2023 1.7m, Q4 2023 3.8m, Q1 2024 2.3m
-1.5m
-1,455,123
-38.5%
41
2SEVENTY BIO INC
COMMON STOCK
TSVT
TSVT
1,177,678
$6.3m0.47%
0.47%
Added Shares held: Q2 2023 0, Q3 2023 1.5m, Q4 2023 1.1m, Q1 2024 1.2m
+38.6k
+38,567
3.4%
42
SUTRO BIOPHARMA INC
COM
COM
1,091,419
$6.2m0.46%
0.46%
Added Shares held: Q2 2023 747.9k, Q3 2023 769.6k, Q4 2023 1.1m, Q1 2024 1.1m
+35.0k
+34,958
3.3%
43
LIQUIDIA CORPORATION
COM NEW
LQDA
LQDA
396,187
$5.8m0.44%
0.44%
Reduced Shares held: Q2 2023 925.4k, Q3 2023 1.4m, Q4 2023 688.9k, Q1 2024 396.2k
-292.7k
-292,739
-42.5%
44
NEVRO CORP
COM
NVRO
NVRO
389,663
$5.6m0.42%
0.42%
New Shares held: Q2 2023 0, Q3 2023 0, Q4 2023 0, Q1 2024 389.7k
45
AMARIN CORP PLC
SPONS ADR NEW
SPONS ADR NEW
6,212,748
$5.5m0.41%
0.41%
Added Shares held: Q2 2023 10.5m, Q3 2023 8.4m, Q4 2023 6.1m, Q1 2024 6.2m
+117.2k
+117,243
1.9%
46
MERUS N V
COM
MRUS
MRUS
119,482
$5.4m0.40%
0.40%
Added Shares held: Q2 2023 131.2k, Q3 2023 134.0k, Q4 2023 115.7k, Q1 2024 119.5k
+3.8k
+3,756
3.2%
47
ICON PLC
SHS
ICLR
ICLR
15,347
$5.2m0.39%
0.39%
Reduced Shares held: Q2 2023 71.7k, Q3 2023 21.0k, Q4 2023 15.4k, Q1 2024 15.3k
-70
-70
-0.5%
48
WATERS CORP
COM
WAT
WAT
13,628
$4.7m0.35%
0.35%
Reduced Shares held: Q2 2023 10.9k, Q3 2023 23.1k, Q4 2023 27.7k, Q1 2024 13.6k
-14.1k
-14,091
-50.8%
49
STOKE THERAPEUTICS INC
COM
STOK
STOK
290,000
$3.9m0.29%
0.29%
New Shares held: Q2 2023 0, Q3 2023 0, Q4 2023 0, Q1 2024 290.0k
50
CORBUS PHARMACEUTICALS HLDGS
COM NEW
CRBP
CRBP
88,934
$3.5m0.26%
0.26%
New Shares held: Q2 2023 0, Q3 2023 0, Q4 2023 0, Q1 2024 88.9k
51
KRYSTAL BIOTECH INC
COM
KRYS
KRYS
18,557
$3.3m0.25%
0.25%
Reduced Shares held: Q2 2023 106.5k, Q3 2023 108.8k, Q4 2023 80.8k, Q1 2024 18.6k
-62.2k
-62,241
-77.0%
52
ALECTOR INC
COM
ALEC
ALEC
536,171
$3.2m0.24%
0.24%
New Shares held: Q2 2023 0, Q3 2023 0, Q4 2023 0, Q1 2024 536.2k
53
AVANTOR INC
COM
AVTR
AVTR
125,394
$3.2m0.24%
0.24%
Reduced Shares held: Q2 2023 0, Q3 2023 84.5k, Q4 2023 126.0k, Q1 2024 125.4k
-570
-570
-0.5%
54
IQVIA HLDGS INC
COM
IQV
IQV
12,178
$3.1m0.23%
0.23%
Reduced Shares held: Q2 2023 18.7k, Q3 2023 23.0k, Q4 2023 12.3k, Q1 2024 12.2k
-85
-85
-0.7%
55
MORPHOSYS AG
SPONSORED ADS
SPONSORED ADS
165,924
$3.0m0.22%
0.22%
New Shares held: Q2 2023 0, Q3 2023 0, Q4 2023 0, Q1 2024 165.9k
56
VIRIDIAN THERAPEUTICS INC
COM
VRDN
VRDN
142,075
$2.5m0.19%
0.19%
Added Shares held: Q2 2023 0, Q3 2023 443.3k, Q4 2023 137.3k, Q1 2024 142.1k
+4.7k
+4,732
3.5%
57
MOLINA HEALTHCARE INC
COM
MOH
MOH
5,828
$2.4m0.18%
0.18%
Reduced Shares held: Q2 2023 21.3k, Q3 2023 12.2k, Q4 2023 6.1k, Q1 2024 5.8k
-289
-289
-4.7%
58
XOMA ROYALTY CORPORATION
COM NEW
XOMA
XOMA
97,065
$2.3m0.17%
0.17%
Added Shares held: Q2 2023 90.0k, Q3 2023 90.0k, Q4 2023 93.7k, Q1 2024 97.1k
+3.3k
+3,338
3.6%
59
INFLARX NV
COM
IFRX
IFRX
1,305,140
$2.0m0.15%
0.15%
Unchanged Shares held: Q2 2023 1.9m, Q3 2023 1.7m, Q4 2023 1.3m, Q1 2024 1.3m
60
VIKING THERAPEUTICS INC
COM
VKTX
VKTX
22,818
$1.9m0.14%
0.14%
New Shares held: Q2 2023 0, Q3 2023 0, Q4 2023 0, Q1 2024 22.8k
61
TERNS PHARMACEUTICALS INC
COM
COM
283,034
$1.9m0.14%
0.14%
New Shares held: Q2 2023 0, Q3 2023 0, Q4 2023 0, Q1 2024 283.0k
62
AEROVATE THERAPEUTICS INC
COM
COM
54,150
$1.6m0.12%
0.12%
Added Shares held: Q2 2023 50.2k, Q3 2023 50.2k, Q4 2023 50.2k, Q1 2024 54.1k
+3.9k
+3,908
7.8%
63
CUREVAC N V
COM
CVAC
CVAC
515,691
$1.6m0.12%
0.12%
Added Shares held: Q2 2023 357.3k, Q3 2023 516.8k, Q4 2023 496.9k, Q1 2024 515.7k
+18.8k
+18,779
3.8%
64
REPLIGEN CORP
COM
RGEN
RGEN
8,237
$1.5m0.11%
0.11%
Reduced Shares held: Q2 2023 66.1k, Q3 2023 16.2k, Q4 2023 10.0k, Q1 2024 8.2k
-1.7k
-1,747
-17.5%
65
SERES THERAPEUTICS INC
COM
COM
1,388,944
$1.1m0.08%
0.08%
Reduced Shares held: Q2 2023 3.1m, Q3 2023 2.4m, Q4 2023 1.8m, Q1 2024 1.4m
-364.6k
-364,594
-20.8%
66
AFFIMED N V
ORDINARY SHS NEW
AFMDQ
AFMDQ
166,460
$882.2k0.07%
0.07%
New Shares held: Q2 2023 0, Q3 2023 0, Q4 2023 0, Q1 2024 166.5k
67
VINCERX PHARMA INC
COM NEW
COM NEW
79,588
$402.7k0.03%
0.03%
New Shares held: Q2 2023 0, Q3 2023 0, Q4 2023 0, Q1 2024 79.6k
68
AC IMMUNE SA
SHS
ACIU
ACIU
124,589
$368.8k0.03%
0.03%
Unchanged Shares held: Q2 2023 124.6k, Q3 2023 124.6k, Q4 2023 124.6k, Q1 2024 124.6k